Posts Tagged ‘health care’

European Commission Approves Symtuza® for the Treatment of HIV-1 In Adults and Adolescents in Europe | Business Wire

BEERSE, Belgium–(BUSINESS WIRE)–Janssen-Cilag International NV (Janssen) today announced that the

European Commission has approved the use of Symtuza®

(darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF])1,

a once-daily darunavir-based single-tablet regimen (STR), for the

treatment of human immunodeficiency virus type 1 (HIV-1) infection in

adults and adolescents aged 12 years and older with body weight of at

least 40 kg. Cobicistat, emtricitabine and tenofovir alafenamide are

from Gilead Sciences, Inc.

The only darunavir-based STR indicated for the treatment of this patient

group, Symtuza® combines the proven efficacy and durability

of darunavir with the improved renal laboratory and bone mineral density

profile of F/TAF as compared to F/TDF (emtricitabine/tenofovir

disoproxil fumarate). It is the only approved treatment to offer the

convenience of a STR alongside the high genetic barrier to resistance

provided by darunavir.

“There are almost one million people in the European Union currently

living with HIV. The availability of a single-treatment regimen with a

high barrier to resistance mutations eliminates the need for separate

tablets, reducing the burden of pills on daily life for patients, and

helping them to achieve improved treatment adherence and viral

suppression,” said Jean-Michel Molina, Professor of Infectious Diseases

at the University of Paris Diderot.

“At Janssen, we are committed to developing effective and innovative

treatments which address the issues of adherence and resistance. Today’s

approval by the European Commission demonstrates our efforts to treat

HIV more simply, helping all those living with HIV to achieve an

undetectable viral load while enjoying an improved quality of life,”

said Lawrence M. Blatt, Ph.D., Global Therapeutic Area Head, Janssen

Infectious Diseases Therapeutics.

Results from a bioequivalence study that compared Symtuza®

with the combined administration of the separate agents darunavir [D]

800 mg, cobicistat [C] 150 mg, and emtricitabine/tenofovir alafenamide

[FTC/TAF] 200 mg/10 mg fixed-dose combination were presented at the

International AIDS Society (IAS) conference in Paris, France in July.2

These results confirmed that the once-daily STR is bioequivalent to the

combined administration of the separate agents, as well as demonstrating

that the STR is well tolerated.

In addition, results from the pivotal Phase 3 EMERALD study presented at

IAS showed that the once-daily STR containing darunavir 800 mg,

cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide 10 mg

[D/C/F/TAF] had a low cumulative virologic rebound rate and a high

virologic suppression rate at 24 weeks in HIV-1 positive, virologically

suppressed adults who switched from a standard boosted protease

inhibitor (PI) plus tenofovir/emtricitabine regimen. A Phase 3 clinical

trial programme investigating the efficacy and safety of the

darunavir-based combination is ongoing. In October, EMERALD 48-week data

will be presented at ID Week 2017 in San Diego, California, USA, and

48-week data from the Phase 3 AMBER trial in antiretroviral therapy

(ART) naïve patients will be presented at the European AIDS Clinical

Society (EACS) Conference in Milan, Italy.3,4

On 20 July, the European Committee for Medicinal Products for Human Use

(CHMP) of the European Medicines Agency (EMA) issued a positive opinion

for Symtuza®.5 This subsequent European Commission

approval allows Janssen to market Symtuza® in all countries

in the European Union and European Economic Area.1

###

Notes to editors

On 23 December 2014, Janssen and Gilead Sciences International Ltd

amended a licensing agreement for the development and commercialisation

of a once-daily STR combination of darunavir and Gilead’s TAF,

emtricitabine and cobicistat. Under the terms of the

agreement, Janssen and its affiliates are responsible for the

manufacturing, registration, distribution and commercialisation of this

STR worldwide.

About Symtuza®

In the European Union, Symtuza® is indicated for the

treatment of human immunodeficiency virus type 1 (HIV-1) infection in

adults and adolescents (aged 12 years and older with body weight at

least 40 kg). Genotypic testing should guide the use of Symtuza®.

Symtuza® is a fixed-dose combination of four active

substances (darunavir, cobicistat, emtricitabine and tenofovir

alafenamide), available as 800 mg/150 mg/200 mg/10 mg film-coated

tablets. Darunavir inhibits the HIV protease and prevents the formation

of mature infectious virus particles. Emtricitabine and tenofovir

alafenamide are substrates and competitive inhibitors of HIV reverse

transcriptase. After phosphorylation, they are incorporated into the

viral DNA chain, resulting in chain termination. Cobicistat enhances the

systemic exposure of darunavir and has no direct antiviral effect.

About the Janssen Pharmaceutical Companies of Johnson & Johnson

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are

working to create a world without disease. Transforming lives by finding

new and better ways to prevent, intercept, treat and cure disease

inspires us. We bring together the best minds and pursue the most

promising science. We are Janssen. We collaborate with the world for the

health of everyone in it. Learn more at www.janssen.com/emea

and follow us at @JanssenEMEA.

Cautions Concerning Forward-Looking

Statements

This press release contains “forward-looking statements” as defined

in the Private Securities Litigation Reform Act of 1995 regarding

development of potential preventive and treatment regimens for HIV. The

reader is cautioned not to rely on these forward-looking statements.

These statements are based on current expectations of future events. If

underlying assumptions prove inaccurate or known or unknown risks or

uncertainties materialize, actual results could vary materially from the

expectations and projections of the Janssen Pharmaceutical Companies and

Johnson & Johnson. Risks and uncertainties include, but are not limited

to: challenges and uncertainties inherent in product development,

including uncertainty of clinical success and obtaining regulatory

approvals; uncertainty of commercial success for new indications and

therapeutic combinations; competition, including technological advances,

new products and patents attained by competitors; challenges to patents;

product efficacy or safety concerns resulting in product recalls or

regulatory action; changes in behaviour and spending patterns of

purchasers of health care products and services; changes to applicable

laws and regulations, including global health care reforms; and trends

toward health care cost containment. A further list and description of

these risks, uncertainties and other factors can be found in Johnson &

Johnson’s Annual Report on Form 10-K for the year ended January 1, 2017,

including under “Item 1A Risk Factors,” its most recently filed

Quarterly Report on Form 10-Q, including in the section captioned

“Cautionary Note Regarding Forward-Looking Statements,” and the

company’s subsequent filings with the Securities and Exchange

Commission. Copies of these filings are available online at www.sec.gov,

www.jnj.com

or on request from Johnson & Johnson. None of the Janssen Pharmaceutical

Companies or Johnson & Johnson undertakes to update any forward-looking

statement as a result of new information or future events or

developments.

1 European Medicines Agency http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004391/smops/Positive/human_smop_001176.jsp&mid=WC0b01ac058001d127

2 9th IAS Conference on HIV Science 2017 http://www.ias2017.org/Portals/1/Files/IAS2017_LO.compressed.pdf?ver=2017-07-27-211231-197

3 ID Week 2017 https://idsa.confex.com/idsa/2017/webprogram/start.html

4 16th European AIDS Conference http://www.eacs-conference2017.com/index.php?article_id=147

5 European Medicines Agency, Symtuza Summary of opinion http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004391/WC500231710.pdf

Be the first to comment - What do you think?  Posted by admin - November 18, 2017 at 1:52 am

Categories: Health   Tags: , , , , , , , ,

Optum and The Advisory Board Company’s Health Care Business to Combine | Business Wire

BOSTON–()–Optum and The Advisory Board Company (NASDAQ: ABCO), announced today

that The Advisory Board Company’s health care business will join Optum.

</p>

<p style="text-align: center">.

About The Advisory Board Company Health Care Business

Headquartered in Washington, D.C., with offices worldwide, Advisory

Board, the health care business of The Advisory Board Company, is a best

practices firm that uses a combination of research, technology and

consulting to improve the performance of more than 4,400 health care

organizations. For more information, visit www.advisory.com.

About Optum

Optum is a leading information and technology-enabled health services

business dedicated to helping make the health system work better for

everyone. With more than 133,000 people worldwide, Optum delivers

intelligent, integrated solutions that help to modernize the health

system and improve overall population health. Optum is part of

UnitedHealth Group (NYSE:UNH). For more information, visit www.optum.com.

Cautionary Statement Regarding Forward-Looking Statements

This communication includes “forward-looking statements” as defined

under U.S. federal securities laws about the proposed transaction.

Generally, the words “believe,” “expect,” “intend,” “estimate,”

“anticipate,” “plan,” “project,” “should,” “will” and similar

expressions identify forward-looking statements, which generally are not

historical in nature. These statements are based on current plans,

estimates and expectations that are subject to risks and uncertainties.

We caution that actual results could differ materially from expected

results, depending on the outcome of certain factors, including (i) the

failure to satisfy the conditions to the completion of the transactions,

including the sale of The Advisory Board Company’s education business to

Vista Equity Partners, approval of the proposed merger by The Advisory

Board Company’s stockholders and the receipt of regulatory approvals on

the terms expected or on the anticipated schedule; (ii) the occurrence

of any event, change or other circumstance that could give rise to the

termination of the merger agreement or the education purchase agreement;

(iii) there may be a material adverse change regarding The Advisory

Board Company or its health care business or its education business,

(iv) the failure to complete or receive the anticipated benefits from

the transactions; (v) operating costs, customer loss and business

disruption (including, without limitation, difficulties in maintaining

relationships with employees, customers, clients or suppliers) may be

greater than expected; (vi) the retention of certain key employees at

The Advisory Board Company; (vii) the parties’ ability to meet

expectations regarding the timing, completion and accounting and tax

treatments of the arrangement; (viii) risks related to diverting

management attention from ongoing business operations; (ix) the outcome

of any legal proceedings that may be instituted against UnitedHealth

Group, Optum, The Advisory Board Company or Vista Equity Partners

related to the transactions; (x) there may be changes in economic

conditions, financial markets, interest rates, political conditions or

changes in federal or state laws or regulations; (xi) there may be

changes in the market price of Evolent Health, Inc.’s Class A common

stock; and (xii) the other factors relating to UnitedHealth Group and

The Advisory Board Company discussed in “Risk Factors” in their

respective Annual Reports on Form 10-K for the most recently ended

fiscal year, and in their other filings with the Securities and Exchange

Commission (SEC), all of which are available at http://www.sec.gov.

None of The Advisory Board Company, UnitedHealth Group or Vista Equity

Partners assume any obligation to update or revise this communication as

a result of new information, future events or otherwise, except as

otherwise required by applicable law. Readers are cautioned not to place

undue reliance on these forward-looking statements that speak only as of

the date hereof.

Additional Information and Where to Find It

The proposed merger will be submitted to the stockholders of The

Advisory Board Company for their consideration. This communication may

be deemed to be solicitation material in connection with the proposed

merger. The Advisory Board Company and UnitedHealth Group intend to file

materials relevant to the proposed merger with the SEC, including The

Advisory Board Company’s proxy statement on Schedule 14A. This

communication is not a substitute for the proxy statement or any other

document that The Advisory Board Company may send to its stockholders in

connection with the proposed merger. BEFORE MAKING ANY VOTING

DECISIONS, THE ADVISORY BOARD COMPANY’S STOCKHOLDERS ARE URGED TO READ

ALL RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE,

INCLUDING THE PROXY STATEMENT FOR THE PROPOSED MERGER, BECAUSE THEY WILL

CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Copies of

the proxy statement and other relevant materials, when filed, will be

available free of charge on the SEC’s web site at http://www.sec.gov

or on The Advisory Board Company’s website at http://investors.advisoryboardcompany.com/Docs/.

Participants in Solicitation

The Advisory Board Company and its directors and executive officers, and

UnitedHealth Group and its directors and executive officers, are deemed

to be participants in the solicitation of proxies from stockholders of

The Advisory Board Company in connection with the proposed merger.

Information about The Advisory Board Company’s directors and executive

officers and their ownership of The Advisory Board Company’s common

stock can be found in its Annual Report on Form 10-K for the year ended

December 31, 2016 filed with the SEC on March 16, 2017, in its

Definitive Proxy Statement for its 2017 Annual Meeting of Stockholders

filed with the SEC on April 21, 2017 and on The Advisory Board Company’s

website at https://www.advisoryboardcompany.com/.

Information about UnitedHealth Group’s directors and executive officers

can be found in its Annual Report on Form 10-K for the year ended

December 31, 2016 filed with the SEC on February 8, 2017 and on

UnitedHealth Group’s website at http://www.unitedhealthgroup.com.

Investors may obtain additional information regarding the interest of

such participants by reading the proxy statement and other materials to

be filed with the SEC in connection with proposed merger when they

become available.

Click

here to subscribe to Mobile Alerts for UnitedHealth Group.

Be the first to comment - What do you think?  Posted by admin - November 14, 2017 at 10:23 pm

Categories: Health   Tags: , , , , , , , ,

New Markets Tax Credit Financing Paves the Way for a New Medical Center in Hilltop | Business Wire

TACOMA, Wash.–(BUSINESS WIRE)–Community

Health Care, a Federally Qualified Health Center serving residents

of Pierce County, Washington, has begun construction of a new $26

million health center in the inner-city Hilltop neighborhood in Tacoma.

The development is being financed with more than $6.9 million of New

Markets Tax Credit (NMTC) equity raised in partnership with U.S.

Bank, The

National Development Council (NDC), and the Low

Income Investment Fund (LIIF).

The new Hilltop Regional Health Center will take the place of the small

clinic that Community Health Care has maintained on the Hilltop for over

35 years. It will include medical and dental clinics, urgent care,

radiology, pediatrics, internal medicine and obstetrics. A total of

17,200 patients will be served at the clinic annually, 600% percent more

than at the existing clinic.

“In a time of economic uncertainty, this innovative source of funding

was a real boon to making sure our important health care facility would

happen,” said David Flentge, President and CEO of Community Health Care.

“Without NMTCs, raising the financing necessary for our new center at

Martin Luther King Jr. Way and Earnest S. Brazill would have been

difficult, to say the least.”

“The need for NMTC financing is greater than ever during a slow economy,

as funding gaps get larger and other sources of capital disappear,” said

Matt Philpott, Director of New Markets, Historic and Renewable Energy

Tax Credit Investments for U.S. Bancorp Community Development

Corporation (USBCDC), the tax credit investment subsidiary of U.S. Bank.

“By utilizing the NMTC Program and leveraging its available resources,

Community Health Care has access to critically needed capital and can

focus more of its efforts on providing the highest quality health care

to those in need.”

Through the NMTC Program, Community Health Care was able to raise over

$21 million of its $26 million capital goal. Financing includes an

allocation of tax credits and more than $6.9 million of NMTC equity from

USBCDC in partnership with NDC and LIIF; a $12 million grant from the

Human Resources Service Administration (HRSA); an $1.5 million grant

from the state of Washington; an $800,000 loan from the City of Tacoma

through NDC’s Grow America Fund; and $1.8 million of capital campaign

funds raised to date by the project sponsor.

“Our commitment to Tacoma is over 30 years old and going strong,” said

Robert W. Davenport, President of NDC. “The Hilltop neighborhood is one

of the most densely populated – and medically underserved – communities

in the area. We’re proud to partner with U.S. Bank, LIIF, and the City

of Tacoma to increase residents’ access to primary care providers and

support the development of a regional service clinic.”

Jim Walton, one of the Co-Chairs of Community Health Care’s capital

campaign, is quick to let people know that with $5 million left to go,

there are still opportunities to help underwrite this significant

project. In addition to an allocation of NMTCs, LIIF is providing bridge

financing to Community Health Center through a partnership with

Philadelphia-based The Reinvestment Fund and the Kresge Foundation as

additional donations are secured.

“Community Health Care’s Hilltop Regional Health Center will bring much

needed medical services, capital investment and jobs to the Hilltop

community. This project is exactly the kind of investment the Low Income

Investment Fund seeks to further our mission of creating opportunity for

low income families and neighborhoods,” said Kimberly Latimer-Nelligan,

Chief Operating Officer of LIIF. “The organization is helping meet the

needs of the uninsured, isolated and medically vulnerable in Pierce

County, and we’re committed to ensuring it can continue to serve as an

important community asset for years to come.”

The new clinic will be a three-story, 54,735 square foot building with

an adjacent three story parking facility. The architects for this

project are Johnson Architecture and Planning and the general contractor

is Abbott Construction. Construction started October 1, 2012 and is

expected to be completed by October 2013.

About Community Health Care
Community Health Care first

started providing care in the Hilltop neighborhood in 1969 in the

basement of the nurse’s convent at St. Joseph’s Hospital. From there it

moved to a rented facility in 1980 and purchased the current facility in

1997. In 2011 the Downtown Clinic served 2,821 patients through 10,036

patient visits. Community Health Care is a Federally Qualified Health

Center that serves Pierce County through five medical clinics and two

dental clinics. At Community Health Care no one is denied care due to

inability to pay. People without insurance are treated on a

sliding-fee-scale based on income and family size. Community Health

Care, in 2011, served 31,719 patients through 121,076 patient visits. Of

those served, eighteen percent were uninsured.

About Low Income Investment Fund
The Low Income Investment

Fund (LIIF) invests capital to support healthy families and communities.

Since 1984, LIIF has served one million people by investing $1 billion.

Over its history, LIIF has provided financing and technical assistance

to create and preserve affordable housing, child care centers, schools,

transit-oriented developments and healthy food retail in distressed

neighborhoods nationwide. LIIF’s work has generated $20 billion in

family income and societal benefits. LIIF has offices in San Francisco,

Los Angeles, New York City and Washington, D.C. For more information

about LIIF, visit www.liifund.org.

About National Development Council
The National Development

Council (NDC) is the oldest national non-profit community and economic

development organization in the U.S. It was founded in 1969 with one

purpose: increasing the flow of capital for investment, jobs and

community development to under served urban and rural areas across the

country. Since that time, NDC has worked with thousands of communities

in every one of the 50 states and Puerto Rico, providing technical

assistance, professional training, investment in affordable housing,

small business financing and direct developer services. NDC has been

using New Markets Tax Credits (NMTC) to support economic and community

development since the program’s inception. NDC not only provides tax

credit equity to our client communities, but also assists communities in

structuring their NMTC deals, finding the necessary additional

financing, and developing relationships with other organizations that

receive allocations of the tax credits. To date NDC has invested over

$587.6 million in 71 projects generating over $1 billion in total

investment. www.nationaldevelopmentcouncil.org.

About the New Markets Tax Credit Program
The New Markets Tax

Credit (NMTC) Program was established by Congress in 2000 to encourage

the investment of private capital in designated low-income communities

in order to create jobs, generate economic activity and improve the

quality of services in low-income communities and to low-income persons.

The NMTC Program attracts investment capital to low-income communities

by permitting individual and corporate investors to receive a tax credit

against their federal income tax return in exchange for making qualified

equity investments in specialized financial institutions called

Community Development Entities (CDEs). Capital raised by the CDEs is

then used to provide below-market financing to qualified businesses in

low-income communities. The credit totals 39 percent of the original

investment amount and is claimed over a period of seven years. For more

information, visit www.cdfifund.gov.

About U.S. Bancorp Community Development Corporation
With

more than $9.8 billion in assets, U.S. Bancorp Community Development

Corporation, a subsidiary of U.S. Bank, provides innovative financing

solutions for community development projects across the country using

state and federally sponsored tax credit programs. USBCDC’s commitments

provide capital investment to areas that need it the most and have

contributed to the creation of new jobs, the rehabilitation of historic

buildings, the construction of needed affordable and market-rate homes,

the development of renewable energy facilities, and the generation of

commercial economic activity in underserved communities. Visit USBCDC on

the web at www.usbank.com/cdc.

About U.S. Bank
U.S. Bancorp (NYSE: USB), with $353 billion

in assets as of June 30, 2012, is the parent company of U.S. Bank, the

fifth-largest commercial bank in the United States. The company operates

3,080 banking offices in 25 states and 5,085 ATMs and provides a

comprehensive line of banking, brokerage, insurance, investment,

mortgage, trust and payment services products to consumers, businesses

and institutions. U.S. Bancorp and its employees are dedicated to

improving the communities they serve, for which the company earned the

2011 Spirit of America Award, the highest honor bestowed on a company by

United Way. Visit U.S. Bancorp on the web at www.usbank.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50437696&lang=en

Be the first to comment - What do you think?  Posted by admin - November 11, 2017 at 2:22 pm

Categories: Health   Tags: , , , , , ,

Eighty-Seven Organizations Call on Congress to Protect Medicaid | Business Wire

BETHESDA, Md.–(BUSINESS WIRE)–Eighty-seven organizations issued a letter today calling on Congress to

take a hard look at the likely significant and life-threatening

consequences of the American Health Care Act on millions of patients.

The organizations represent Americans with complex health needs who rely

on Medicaid for access to care, prevention and treatment.

For example, Medicaid supports:

  • Roughly half of all births – helping pregnant woman and infants

    receive care;

  • Nearly a third of pediatric cancer patients; and

  • Half of children and a third of adults with cystic fibrosis.

The American Health Care Act would cut Medicaid funds and reduce

eligibility with the goal of cost savings, but at the expense of

patients who rely on this vital safety net for their life-sustaining

health care needs. Millions of patients would be left without Medicaid

coverage under this proposal, threatening their ability to maintain

their health and well-being. We implore Congress to take urgent action

to protect constituents and communities across the nation.

See below for the full text of the letter and complete list of

organizations that signed on.

March 20, 2017

The Honorable Mitch McConnell
Senate Majority Leader
U.S.

Capitol Building, S-230
Washington DC 20510

The Honorable Paul Ryan
Speaker of the House
U.S. Capitol

Building, H-232
Washington, DC 20515

Dear Leader McConnell and Speaker Ryan:

The undersigned organizations write to express grave concern about

proposals put forth in the American Health Care Act (AHCA) to alter the

fundamental structure and purpose of Medicaid, a vital source of health

care for patients with ongoing health needs.

We feel compelled to speak out against proposals to phase out Medicaid

expansion and implement per capita caps, which threaten the ability of

Medicaid to provide critical health care services to many of our most

vulnerable citizens. These proposals aim to achieve cost savings of

approximately $880 billion, according to the Congressional Budget

Office, at the expense of tens of millions of patients who rely on

Medicaid for life-sustaining care.1 While we appreciate the

opportunities we have had to work with your staff, we cannot support the

Medicaid provisions in this bill and cannot accept policies that

prioritize cutting costs by limiting patients’ access to care.

Medicaid is Critical for Patients
Medicaid is a crucial

source of coverage for patients with serious and chronic health care

needs. Pregnant women depend on Medicaid, which covers roughly 50

percent of all births including many high-risk pregnancies.2

Medicaid covers cancer patients: nearly one-third of pediatric cancer

patients were enrolled in Medicaid in 2013 and approximately 1.52

million adults with a history of cancer were covered by Medicaid in 2015.3

Over fifty percent of children and one-third of adults living with

cystic fibrosis rely on Medicaid to get the treatments and therapies

they need to preserve their health.4 Nearly half of children

with asthma are covered by Medicaid or CHIP and adults with diabetes are

disproportionally covered by Medicaid as well.5,6 The

patients we represent are eligible for Medicaid through various

pathways, including through income-related and disability criteria.

Reject Per Capita Caps
The proposal to convert federal

financing of Medicaid to a per capita cap system is deeply troubling.

This policy is designed to reduce federal funding for Medicaid, forcing

states to either make up the difference with their own funds or cut

their programs by reducing the number of people they serve and the

health benefits they provide.

For patients with ongoing health care needs, this means that Medicaid

may no longer cover the care and treatments they need, including

breakthrough therapies and technology. In order to save money, the per

capita caps are set to grow more slowly than expected Medicaid costs

under current law.7 As the gap between the capped allotment

and actual costs increases over time, states will be forced to constrain

eligibility, reduce benefits, lower provider payments, or increase

cost-sharing. Moreover, by capping the federal government’s contribution

to Medicaid in this manner, states will be less able to cover the cost

of new treatments. This could be devastating for people with serious

diseases, for whom groundbreaking treatments represent a new lease on

life. For people with cystic fibrosis, cancer, and other diseases, new

therapies can be game changers that improve quality of life and increase

life expectancy. In fact, we have already seen Medicaid programs respond

to current budget constraints by using clinically inappropriate criteria

to restrict access to therapies old and new. A per capita cap will only

exacerbate the downward pressure on Medicaid budgets and will further

reduce access to these therapies for patients.

Pairing financing reforms with increased flexibility, as has often been

proposed, would further undermine Medicaid’s role as a safety net for

patients. Without current guardrails provided by federal

requirements—coupled with reduced federal funding—states will have the

authority to reduce benefits and eligibility as they see fit and to

impose other restrictions, such as waiting periods and enrollment caps.

These policies have serious implications for patients—for a person with

cancer, enrollment freezes and waiting lists could mean a later-stage

diagnosis when treatment costs are higher and survival is less likely.

For a person with diabetes, this would risk the ability to adequately

manage the disease. Many of our patients rely on costly services that

will be quickly targeted for cuts if states are given such flexibility,

so it is imperative that current federal safeguards remain in place.

Maintain Medicaid Expansion
While the AHCA has been

described as preserving Medicaid expansion for those already enrolled in

coverage, we are concerned that estimates show that eliminating the

enhanced match for any enrollee with even a small gap in coverage would

actually result in millions of people losing coverage.8,9 By

eliminating the enhanced federal match for any enrollee with a gap in

coverage, eventually states will be on the hook for billions of dollars

to continue covering this population—an insurmountable financial hurdle.

Additionally, seven states have laws that would effectively end Medicaid

expansion immediately or soon thereafter when the expansion match rate

is eliminated. Nearly half of adults covered by the Medicaid expansion

are permanently disabled, have serious physical or mental

conditions—such as cancer, stroke, heart disease, arthritis, pregnancy,

or diabetes—or are in fair or poor health.11 Repealing

Medicaid expansion will leave these patients without coverage they

depend upon to maintain their health.

The proposed financing reforms are a fundamental shift away from

Medicaid’s role as a safety-net for some of the most vulnerable members

of our society. Repealing Medicaid expansion would leave millions

without the health care they rely on. Our organizations represent and

provide care for millions of Americans living with ongoing health care

needs who rely on Medicaid and we cannot support policies that pose such

a grave risk to patients.

We hope that we can continue our dialogue as you move forward in this

process to arrive at solutions that provide all Americans with

high-quality, affordable care regardless of an individual’s income,

employment status, health status, or geographic location.

Sincerely,

 

ADAP Advocacy Association

AIDS Action Baltimore

The AIDS Institute

Alpha-1 Foundation

Alport Syndrome Foundation

ALS Association

American Academy of Pediatrics

American Behcet’s Disease Association

American Congress of Obstetricians and Gynecologists

American Diabetes Association

American Lung Association

American Parkinson Disease Association

American Society of Hematology

American Thoracic Society

Amyloidosis Support Groups Inc.

ARPKD/CHF Alliance

Arthritis Foundation

Batten Disease Support & Research Association

Bladder Cancer Advocacy Network

Bridge the Gap – SYNGAP Education and Research Foundation

Bronx Lebanon Hospital Center Department of Family Medicine

CADASIL Together We Have Hope Non-Profit

Cancer Support Community

Child Neurology Foundation

Children’s Cause for Cancer Advocacy

Children’s Dental Health Project

Chronic Illness and Disability Partnership

Community Access National Network

Congenital Adrenal Hyperplasia Research Education & Support

Foundation, Inc.

COPD Foundation

Cure HHT

Cutaneous Lymphoma Foundation

Cystic Fibrosis Foundation

Cystinosis Research Network

debra of America

Endocrine Society

Fibrous Dysplasia Foundation

First Focus Campaign for Children

FORCE: Facing Our Risk of Cancer Empowered

Foundation for Prader-Willi Research

Friedreich’s Ataxia Research Alliance (FARA)

Genetic Alliance

Hannah’s Hope Fund

Hide & Seek Foundation for Lysosomal Disease Research

Hispanic Health Network

Hope for Hypothalamic Hamartomas

Huntington’s Disease Society of America

Immune Deficiency Foundation

The International Pemphigus and Pemphigoid Foundation

Kids v Cancer

Latino Commission on AIDS

LFS Association (Li-Fraumeni Syndrome Association)

Liver Health Connection

March of Dimes

Medicare Rights Center

MLD Foundation

Moebius Syndrome Foundation

Muscular Dystrophy Association (MDA)

NASTAD (National Alliance of State & Territorial AIDS Directors)

National Alliance on Mental Illness

National Coalition for Cancer Survivorship

National Health Law Program

National Hemophilia Foundation

National Multiple Sclerosis Society

National Organization for Rare Disorders

National Patient Advocate Foundation

National Tay-Sachs & Allied Diseases Association (NTSAD)

National Urea Cycle Disorders Foundation

National Viral Hepatitis Roundtable

NBIA Disorders Association

Needle Exchange Emergency Distribution (NEED)

Parent Project Muscular Dystrophy (PPMD)

Parkinson Alliance

The PCD (Primary Ciliary Dyskinesia) Foundation

Polycystic Kidney Disease Foundation

Pulmonary Fibrosis Foundation

PXE International

Rett Syndrome Research Trust

Scleroderma Foundation

The Sudden Arrhythmia Death Syndromes Foundation

T1D Exchange

Trisomy 18 Foundation

Tuberous Sclerosis Alliance

United Way Worldwide

VHL Alliance

Wilson Disease Association

Wishes for Elliott: Advancing SCN8A Research

Be the first to comment - What do you think?  Posted by admin - November 10, 2017 at 11:04 pm

Categories: Health   Tags: , , , , , ,

Health Care: Is It A Right, Privilege, Or Some Combination?

Isn’t it a shame, that our elected representatives, spend far more time, with political manipulations, than serving the best interests of their constituents, and the nation, they are supposed to serve and represent? Nowhere is this more obvious, than by the discussions and debates, regarding health care! Since the Affordable Care Act was enacted in 2010, the Republican legislators have dedicated much time, effort on resources, on blaming and complaining, and trying to reverse and/ or repeal the legislation, coining the phrase, Repeal and Replace. Like many things, which are politically motivated, this was largely, empty rhetoric and promises, which became evident, this year, by the fact, even after more than 6 years of complaining, the G.O.P. came forth with no viable alternative. While there is little doubt, this legislation is flawed, wouldn’t it make more sense, to tweak and improve it, rather than reject the improvements, it has introduced. When more people will be uninsured, or significantly, under – insured, by the changes they have introduced, and those with pre – existing conditions, will lose many of their protections, how does that make health care, better? We proudly claim, our nation, is the best, most advanced country in the world, yet, nowhere, is the cost, even close to what we pay! Doesn’t it seem strange, prescription drugs, are more expensive here, than anywhere else? This issue is not a simplistic one, as the political rhetoric of President Donald Trump, originally indicated and articulated, but playing, political football, with the lives of constituents, is never the right approach. However, whether it is the nay – sayers on the political right, or the Medicare for All propositions, from the progressive wing, we need and deserve solutions, rather than rhetoric!

Dr. Canada Health Insurance Commercial #1 – watch more funny videos

(adsbygoogle = window.adsbygoogle || []).push({});

Be the first to comment - What do you think?  Posted by admin - at 11:03 pm

Categories: Health   Tags: , , , , , , ,

Kaiser Permanente Southern California Leads the Nation in Breast Cancer Screening | Business Wire

PASADENA, Calif.–(BUSINESS WIRE)–Today, Kaiser Permanente physicians and employees throughout Southern

California are celebrating mammograms. The National Committee on Quality

Assurance (NCQA), a private, non-profit organization dedicated to

improving health care quality, recently released its Quality Compass®

report for 2008. The data show that among all reporting health plans

across the nation, Kaiser Permanente in Southern California has the

highest breast cancer screening rate for women aged 52 to 69.

“Our leading performance in breast cancer

screening rates results from a combination of the best technology, great

teamwork, and the most valuable tool for promoting good health –

the human interaction of person to person contact,”

said Jeffrey Weisz, MD, executive medical director for the Southern

California Permanente Medical Group. “We have

made it our mission to reach out to every woman between the ages of 52

to 69, reminding them, coaxing them, and making it easy for them

to get their mammograms.”

Kaiser Permanente’s electronic medical record

system, KP HealthConnect, flags the file of each woman who is due for a

mammogram. When the record comes up at any visit, the check-in

receptionist, nurse, or physician, even those in orthopedics,

ophthalmology, or any specialty, will remind the patient that walk-in

mammograms are available. Whether it was for an injured ankle or an eye

exam, after the original visit, the patient can make a future mammogram

appointment or go immediately to get a mammogram. For those who put off

their breast cancer screening, or never come for a visit, there are

follow-up letters, reminders, and personal phone calls.

“I’ve always been

good about getting my mammograms but there was a lot going on in my life

and I just kept putting it off month after month,”

said Mary Gonzales, age 67, Kaiser Permanente member and patient at the

Baldwin Park Medical Center. “The day I went

to the allergy department, Susan Salas, the receptionist, reminded me

that I was overdue for my mammogram. That was the extra nudge I needed

to make the appointment, thank goodness! The results showed a spot,

something I could not have felt on my own. It turned out to be two types

of a very aggressive cancer. After going over my treatment options with

my doctor, I talked it over with my wonderful family, and with their

support, I decided that a mastectomy would definitely be the right

decision for me. I will always be thankful to Susan –

and to Kaiser Permanente for caring so much about my health.”

This year’s 2008 Quality Compass report

showed that of all reporting health plans, Kaiser Permanente Southern

California had the highest breast cancer screening rate in the nation,

with more than 87 out of 100 women patients age 52 to 69 receiving their

recommended mammograms. The national average is slightly over 72 out of

100. Quality Compass is designed to provide benefits

managers, health plans, consultants, the media, and others with easy

access to comprehensive information about health plan quality and

performance.

“This reaffirms that Kaiser Permanente

Southern California is the health care quality leader for breast cancer

screenings,” said Benjamin Chu, MD,

president, Kaiser Permanente Southern California. “This

report reflects the commitment of our physicians, nurses, health care

professionals, as well as our clerical and support staff at every point

of contact with our patients. We are focused on providing the best

quality care to our patients. From the moment you walk through the door,

your good health is our priority.”

NCQA accredits and certifies a wide range of health care organizations

and manages the evolution of the Healthcare Effectiveness Data and

Information Set, HEDIS®, the performance tool

used by more than 90 percent of the nation’s

health plans.

Consumers can easily access organizations’

NCQA Accreditation and Certification statuses and other information on

health care quality on NCQA’s Web Site at www.ncqa.org,

or by calling NCQA Customer Support at 888-275-7585.

Kaiser Permanente is one of the nation’s

leading integrated health plans. Founded in 1945, it is a nonprofit,

group practice prepayment program with Southern California headquarters

in Pasadena, California. Kaiser Permanente serves the health care needs

of 3.3 million members in Southern California. Today it encompasses the

nonprofit Kaiser Foundation Health Plan, Inc., Kaiser Foundation

Hospitals and their subsidiaries, and the for-profit Southern California

Permanente Medical Group. Kaiser Permanente’s

Southern California Region includes more than 55,800 technical,

administrative and clerical employees and caregivers, and more than

6,400 physicians representing all specialties. More information about

Kaiser Permanente can be found at www.kaiserpermanente.org.

HEDIS® is a registered trademark of the

National Committee for Quality Assurance (NCQA).

The source for data contained in this publication is Quality Compass®

2008 and is used with the permission of the National Committee for

Quality Assurance (NCQA). Any analysis, interpretation, or

conclusion based on these data is solely that of the authors, and NCQA

specifically disclaims responsibility for any such analysis,

interpretation, or conclusion. Quality Compass is a registered

trademark of NCQA.

Be the first to comment - What do you think?  Posted by admin - at 11:03 pm

Categories: Health   Tags: , , , , , , , , ,

Who Should really Fork out For Our Wellbeing Care?

The debate goes on, should the government be liable for providing our wellness treatment?

There are numerous arguments for and from national health care.

At one time, every person was liable for their very own wellness, there was no insurance. In that working day and age, clinical treatment was a great deal less costly than it is right now, even getting into account the fee of inflation above the several years.

The rise in cost has in section is mainly because of all the new technologies out there right now, but to a big degree, the rising cost is due to elevated demand.

Because of the transform in our national mentality, in a big section due to negotiated union contracts, every person thinks their wellness treatment is free of charge. Most have come to believe that it is a ideal, a ideal no one pays for.

I’m a company believer that economical health care should be out there to every person.

Nevertheless, mainly because of the existing technique, extremely handful of men and women recognize the cost of wellness treatment, and mainly because it is presumably free of charge to them, they go to the medical doctor for each tiny sniffle they get. Numerous visits are unwanted and highly-priced. Individuals go to the unexpected emergency place for a skinned knee, or a splinter in their hand, these emergencies could be taken treatment of at dwelling.

It has become “trendy” to go to the unexpected emergency place.

Wellbeing insurance should be compensated for by the person. If just about every person was liable for their health care, they would become extra well-informed on what “performs” and what doesn’t.

Most organizations that present wellness insurance allocate a certain volume of wages for the…



by

Be the first to comment - What do you think?  Posted by admin - November 9, 2017 at 12:31 pm

Categories: Health   Tags: , , , , , , , , , , , , , , , , , , , , , ,

University of South Alabama Bolsters Online Nursing and Health Sciences Programs with i-Human Patients | Business Wire

MOBILE, Ala.–(BUSINESS WIRE)–The

University of South Alabama (USA), one of the nation’s premier

schools for simulation in health sciences education, has expanded its

use of i-Human

Patients, Inc.’s (IHP) virtual training platform to further augment

its online curricula. The university has already implemented i-Human in

its graduate nursing and physician assistant programs, and plans to

expand to some undergraduate courses as well. More than 1,400 students

will hone their skills on the platform this fall, following a successful

summer session in which more than 900 students used the platform.

USA’s simulation program has more than 30,000 simulated student

encounters every year, but with one of the largest online nursing

schools in the country, the university needed a way to consistently

expose its online graduate nursing students to simulations as well. The

i-Human platform now allows remote students new opportunities to conduct

simulations, hone their diagnostic reasoning, and improve their clinical

competencies.

The i-Human

platform’s interactive learning environment enriches students’

clinical detective skills and history-taking abilities through

interactions with virtual patients, in addition to their reading and

online lectures. Educators can incorporate the platform’s hundreds of

case scenarios into their curricula to teach or expand upon clinical

concepts. USA will use i-Human for classroom instruction, simulated

clinical encounters, and assessments of students’ skills.

“Practice makes perfect, and we offer our students a lot of practice,”

said Dr. Mike Jacobs, Professor and Director of USA’s Human Simulation

Program. “i-Human Patients adds a new dynamic platform to our simulation

program, allowing us to offer students a low-stress, low-risk

environment to absorb core competencies that they can then replicate

with higher levels of confidence and performance in real-world patient

encounters.”

The i-Human platform also allows USA to meet growing demand for

interprofessional learning and simulation across disciplines. Despite

the wealth of common content, finding time and space to conduct

simulated patient encounters across different schools remains a

challenge. The i-Human platform, available anytime and anywhere, grants

students more opportunities to focus on the common content that

stretches across all fields of health care, such as taking a health

history and accurately reading test results.

IHP

has created a more active learning environment, which is hard to

achieve online,” said Dr. Alison Rudd, Assistant Professor and Assistant

Director of Simulation at USA. “Students are seeing patients before they

actually see patients. When they engage these virtual patients online,

they’re able to apply the concepts they learn from the textbook and

through readings as they collect a health history and perform a physical

examination.”

“Students improve upon critical talents during patient simulations, and

i-Human further strengthens and enhances those skills and competencies

anytime and anywhere,” said Norm Wu, CEO of IHP. “USA’s implementation

of the i-Human platform shows how virtual simulation complements other

forms of simulation and underscores the importance of high-quality,

frequent practice for students of all education levels and across all

disciplines. i-Human will help USA sharpen students’ assessment skills

and critical thinking through virtual encounters that improve patient

outcomes in the real world.”

About i-Human Patients, Inc.

i-Human Patients, Inc. develops educational technology for the student

and practicing health care professional market, including its flagship

i-Human Patients® platform, launched in November 2012.

Cloud-based and interactive, the i-Human case player improves cognitive

learning outcomes for students using active learning strategies and

content developed by almost 100 leading educators.

IHP is collaborating with the Reliance

Foundation, an Indian not-for-profit organization that has provided

generous support to enhance the i-Human platform and add numerous new

simulated patient encounter cases. The partnership aims to provide

high-quality virtual health care training to students and clinicians,

and equip health care professionals to achieve greater standards of

excellence. IHP has also received financial support from the American

Medical Association and the National Science Foundation. i-Human

Patients, Inc. is based in Sunnyvale, California.

About University of South Alabama

The University of South Alabama is a comprehensive, global university

that provides students a quality education in business, the liberal

arts, education, engineering, computing, the sciences and health care.

USA offers 100 undergraduate, graduate and doctoral degrees through its

nine colleges and schools, and is ranked Research University/High by the

Carnegie Foundation for the Advancement of Teaching.

The University of South Alabama annually enrolls more than 16,000

students and has awarded more than 80,000 degrees in its 52-year

history. USA is also an economic driver for the central Gulf Coast, with

an annual economic impact exceeding $3 billion.

In health care, USA plays a dual role by providing students outstanding

medical education through our colleges of Medicine, Nursing and Allied

Health Professions, and the region with advanced and innovative care

through the USA Physicians Group, USA Medical Center, USA Children’s &

Women’s Hospital and the USA Mitchell Cancer Institute. For more

information, please visit the University of South Alabama home page, www.southalabama.edu.

Be the first to comment - What do you think?  Posted by admin - November 8, 2017 at 5:02 am

Categories: Health   Tags: , , , , , , , , ,

Low-Earnings Health and fitness Treatment Reform – How Functioning Families Are Impacted

Financial Pressures and the Labor Market place

Right now, there are about 150 Americans lined as element of an employer-sponsored overall health care program and this security blanket is ever more at chance with an unsure work marketplace. In truth, now unemployment stays above ten% on the national degree and replacement work characteristic many fewer gains than traditional salaried or union-centered positions. The decrease in personnel gains is a product or service of the declining arranged labor motion, as Union centered employment has fallen under nine% in all sectors (with a lot higher proportions in the public sector) which is a lot reduced than equally the historic typical and unionization fees in other formulated countries.

According to the AFL-CIO, a person of the single biggest labor organizers, about 3/4 of all Union employees have some form of overall health coverage gains connected to their work. Consequently, the decrease in union-centered employees has resented in reduced stages of combination protection, in particular as extra employees return to the labor power as contractors, element-time employees or seasonal employers in positions which absence gains. Unemployed employees are in a position to keep the identical protection fees as their past overall health plans for up to twelve-months under COBRA, but these employees also should pay back for the fees, co-payments and quality raise of their very own pockets.

Economical Health and fitness Treatment for Families

Whilst unemployment gains and subsidy programs can support reduce small-time period pressures, overall health care reform should…



by

Be the first to comment - What do you think?  Posted by admin - at 12:42 am

Categories: Health   Tags: , , , , , , , , , , , , , , , , , , , , , ,

Florida Wellness Insurance

Florida wellbeing insurance refers to insurance offered by wellbeing insurance businesses for the residents of Florida. The insurance provider could be a federal government company or a private group. In accordance to the strategy decided on, the insurer pays the health care costs of the insured if the insured results in being sick due to covered will cause, or due to incidents.

Florida heath insurance businesses predominantly provide two styles of insurance – indemnity programs and managed treatment programs. With indemnity programs, the insurer reimburses the insured for health care charges no matter who gives the support. The indemnity category consists of three distinct programs, which contain reimbursement of actual rates, reimbursement of a % of the actual rates, and indemnity. With the 1st strategy, the insurance provider will reimburse for the whole cost of the support, the next strategy addresses a percentage, even though the indemnity will deal with a definite volume every day for a specified variety of days.

There are predominantly three styles of managed treatment programs – HMOs (Wellness Maintenance Organizations), PPOs (Desired Provider Organizations), and POSs (Place of Services programs). In accordance to the HMO strategy, the insured has to pay a flat regular amount. PPOs are paid on a support-by-support basis. PPOs are commonly sponsored by insurance businesses or companies who reimburse the insured for the support. In a POS strategy the insured pays a small co-payment as prolonged as the support provider is a element of the community.

The charges for Florida wellbeing insurance fluctuate…



by

Be the first to comment - What do you think?  Posted by admin - November 5, 2017 at 4:37 pm

Categories: Health   Tags: , , , , , , , , , , , , , , , , , , , , , ,

Next Page »